 Shares of ReShape Lifesciences commenced trading on The Nasdaq Capital Market at market open on June 16, 2021 under the ticker symbol RSLS SAN CLEMENTE, CA ACCESSWIRE June 17, 2021 ReShape Lifesciences Inc. NASDAQ:RSLS, a global weight-loss solutions leader, announced that its common stock effectively traded at a first day volume of over 3.5 million shares on The Nasdaq Capital Market under the ticker symbol RSLS, following the previously announced completion of its merger with Obalon Therapeutics, Inc. Listing on Nasdaq has been one of the Companys top strategic goals, and we are very pleased to have achieved this important milestone, commented Bart Bandy, President and Chief Executive Officer of ReShape Lifesciences. We are excited to capitalize on the benefits of being a Nasdaq listed company and deliver on our mission to become the premier physician led weight loss solutions company, currently anchored by the Lap-Band System with over 1,000,000 worldwide placements and the companys recently launched reshapecareTM virtual health program that is reimbursed through many major insurance carriers. 